ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
13.75
+0.92 (7.17%)
Jun 6, 2025, 1:43 PM - Market open
ClearPoint Neuro Revenue
ClearPoint Neuro had revenue of $8.49M in the quarter ending March 31, 2025, with 11.07% growth. This brings the company's revenue in the last twelve months to $32.24M, up 23.22% year-over-year. In the year 2024, ClearPoint Neuro had annual revenue of $31.39M with 31.04% growth.
Revenue (ttm)
$32.24M
Revenue Growth
+23.22%
P/S Ratio
10.98
Revenue / Employee
$280,313
Employees
115
Market Cap
388.64M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 31.39M | 7.44M | 31.04% |
Dec 31, 2023 | 23.96M | 3.40M | 16.56% |
Dec 31, 2022 | 20.55M | 4.25M | 26.09% |
Dec 31, 2021 | 16.30M | 3.47M | 27.05% |
Dec 31, 2020 | 12.83M | 1.61M | 14.37% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
CLPT News
- 17 days ago - I Missed The Quantum Rally - I Won't Miss The Next One - Seeking Alpha
- 23 days ago - ClearPoint Neuro, Inc. (CLPT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - ClearPoint Neuro Reports First Quarter 2025 Results - Accesswire
- 24 days ago - ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing - Accesswire
- 5 weeks ago - ClearPoint Neuro: Fundamentals Continue To Strengthen - Seeking Alpha
- 5 weeks ago - ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI - Accesswire
- 6 weeks ago - ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025 - Accesswire
- 6 weeks ago - ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 - Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room - Accesswire